Samir B. Kahwash

2.1k total citations · 1 hit paper
97 papers, 1.2k citations indexed

About

Samir B. Kahwash is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Samir B. Kahwash has authored 97 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Hematology, 24 papers in Public Health, Environmental and Occupational Health and 16 papers in Molecular Biology. Recurrent topics in Samir B. Kahwash's work include Acute Myeloid Leukemia Research (43 papers), Acute Lymphoblastic Leukemia research (22 papers) and Lymphoma Diagnosis and Treatment (11 papers). Samir B. Kahwash is often cited by papers focused on Acute Myeloid Leukemia Research (43 papers), Acute Lymphoblastic Leukemia research (22 papers) and Lymphoma Diagnosis and Treatment (11 papers). Samir B. Kahwash collaborates with scholars based in United States, Canada and Malaysia. Samir B. Kahwash's co-authors include Todd A. Alonzo, Alan S. Gamis, Susana C. Raimondi, Soheil Meshinchi, Betsy Hirsch, Robert B. Gerbing, Richard Aplenc, Lillian Sung, Amy Heerema‐McKenney and Laura Winter and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Samir B. Kahwash

87 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531

2014 313 citations Alan S. Gamis, Todd A. Alonzo et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Samir B. Kahwash United States	18	688	381	308	260	135	97	1.2k
Marie‐Christiane Vekemans Belgium	14	456 0.7×	206 0.5×	255 0.8×	195 0.8×	169 1.3×	40	838
Mouhab Ayas Saudi Arabia	21	756 1.1×	296 0.8×	316 1.0×	261 1.0×	251 1.9×	92	1.3k
Sudipto Mukherjee United States	17	573 0.8×	173 0.5×	258 0.8×	319 1.2×	283 2.1×	139	1.2k
Guillermo Debén Spain	15	720 1.0×	304 0.8×	578 1.9×	244 0.9×	290 2.1×	35	1.3k
A Nagler Israel	18	974 1.4×	282 0.7×	156 0.5×	352 1.4×	179 1.3×	42	1.4k
Jayesh Mehta United States	16	605 0.9×	94 0.2×	258 0.8×	343 1.3×	166 1.2×	48	1.0k
Deok‐Hwan Yang South Korea	20	488 0.7×	203 0.5×	256 0.8×	437 1.7×	169 1.3×	124	1.3k
Paolo Alberto Paciucci United States	17	568 0.8×	247 0.6×	243 0.8×	423 1.6×	98 0.7×	32	1.1k
Guillermo Martı́n Spain	23	1.6k 2.3×	449 1.2×	1.1k 3.5×	402 1.5×	304 2.3×	75	2.1k
Edward G. Weir United States	17	313 0.5×	161 0.4×	177 0.6×	267 1.0×	149 1.1×	25	914

Countries citing papers authored by Samir B. Kahwash

Since Specialization

Citations

This map shows the geographic impact of Samir B. Kahwash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samir B. Kahwash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samir B. Kahwash more than expected).

Fields of papers citing papers by Samir B. Kahwash

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samir B. Kahwash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samir B. Kahwash. The network helps show where Samir B. Kahwash may publish in the future.

Co-authorship network of co-authors of Samir B. Kahwash

This figure shows the co-authorship network connecting the top 25 collaborators of Samir B. Kahwash. A scholar is included among the top collaborators of Samir B. Kahwash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samir B. Kahwash. Samir B. Kahwash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kahwash, Samir B., et al.. (2023). Differentiating fulminant EBV infection complicated by HLH from Lymphoma: report of a case and a brief literature review. Diagnostic Pathology. 18(1). 28–28. 3 indexed citations

Kahwash, Samir B., et al.. (2023). Long term survivor of MOZ-p300 therapy-related acute myeloid leukemia after matched unrelated donor bone marrow transplantation. Leukemia & lymphoma. 64(7). 1344–1347.

Bunch, Dustin R., et al.. (2022). Medium-chain acyl-CoA dehydrogenase deficiency (MCADD) precipitating unexpected death in an infant: Report of a case and a brief review of literature.. PubMed. 44(3). 523–526. 2 indexed citations

Wong, Yin Ping, O. Hans Iwenofu, Aatur D. Singhi, et al.. (2022). Selective Immunoreactivity for WT1 Carboxy-Terminus Distinguishes Desmoplastic Small Round Cell Tumor From its Histologic Mimics. Pediatric and Developmental Pathology. 25(5). 504–510. 1 indexed citations

Kahwash, Samir B., et al.. (2021). Closing the Brief Case: A 6-Year-Old with Fever, Abdominal Pain, and Recent Travel to Sierra Leone. Journal of Clinical Microbiology. 59(11). 1 indexed citations

Brodersen, Lisa Eidenschink, Robert B. Gerbing, Todd A. Alonzo, et al.. (2020). Morphologic remission status is limited compared to ΔN flow cytometry: a Children’s Oncology Group AAML0531 report. Blood Advances. 4(20). 5050–5061. 20 indexed citations

Rose, Gary S., Christina A. Arnold, Kamran Badizadegan, et al.. (2019). Cytoplasmic Fibrillar Aggregates in Gallbladder Epithelium Are a Frequent Mimic of Cystoisospora in Pediatric Cholecystectomy Specimens. Archives of Pathology & Laboratory Medicine. 143(10). 1259–1264. 3 indexed citations

Dvorak, Christopher C., Prakash Satwani, Elliot Stieglitz, et al.. (2018). Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study. Pediatric Blood & Cancer. 65(7). e27034–e27034. 23 indexed citations

Tarlock, Katherine, Todd A. Alonzo, Michael R. Loken, et al.. (2017). Disease Characteristics and Prognostic Implications of Cell-Surface FLT3 Receptor (CD135) Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group. Clinical Cancer Research. 23(14). 3649–3656. 20 indexed citations

10.

Tan, Geok Chin, et al.. (2017). That's Not Supposed to Be There: An Unusual Finding on Urinalysis. Clinical Chemistry. 63(10). 1660–1661.

11.

Getz, Kelly, Todd A. Alonzo, Lillian Sung, et al.. (2017). Four versus five chemotherapy courses in patients with low risk acute myeloid leukemia: A Children’s Oncology Group report.. Journal of Clinical Oncology. 35(15_suppl). 10515–10515. 7 indexed citations

12.

Kahwash, Samir B., et al.. (2015). Cutaneous Angiomyolipoma Masquerading as a Neurofibroma in a Child with Neurofibromatosis Type 1: A Case Report. Pediatric Dermatology. 32(3). 423–424. 4 indexed citations

13.

Gamis, Alan S., Todd A. Alonzo, Soheil Meshinchi, et al.. (2014). Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531. Journal of Clinical Oncology. 32(27). 3021–3032. 313 indexed citations breakdown →

14.

Gamis, Alan S., Richard Aplenc, Todd A. Alonzo, et al.. (2013). Gemtuzumab Ozogamicin (GO) In Children With De Novo Acute Myeloid Leukemia (AML) Improves Event-Free Survival (EFS) By Reducing Relapse Risk – Results From The Randomized Phase III Children’s Oncology Group (COG) Trial, AAML0531. Blood. 122(21). 355–355. 11 indexed citations

15.

Alonzo, Todd A., Robert B. Gerbing, Samir B. Kahwash, et al.. (2013). Abnormalities Of 12p Are Associated With High-Risk Acute Myeloid Leukemia: A Children’s Oncology Group Report. Blood. 122(21). 612–612. 9 indexed citations

16.

Baker, Peter B., et al.. (2011). Burkitt's Leukemia with an Atypical Immunophenotype: Report of a Case and Review of Literature. PubMed. 17(4). 27–31. 2 indexed citations

17.

Sung, Lillian, Todd A. Alonzo, Robert B. Gerbing, et al.. (2010). High Mortality In Extreme Hyperleukocytosis In Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group.. Blood. 116(21). 1072–1072. 1 indexed citations

18.

Hammond, Sue, et al.. (2009). The Coinheritance of β- and α- Thalassemia: A Review of One Patient and Her Family. PubMed. 15(3). 30–33. 2 indexed citations

19.

Park, Anna, Kenneth E. Morgenstern, Samir B. Kahwash, & Jill A. Foster. (2004). Pediatric Canaliculitis and Stone Formation. Ophthalmic Plastic and Reconstructive Surgery. 20(3). 243–246. 19 indexed citations

20.

Kahwash, Samir B., et al.. (1999). Burkitt's lymphoma in children: A 50-year experience at a single mid-Ohio, USA institution. 6(3). 199–207. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact